Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Gastroenterologia Y Hepatologia|October 11, 2021
Perception and clinical decisions from inflammatory bowel diseases' specialists towards positioning of new therapies in Crohn's disease and ulcerative colitis: A national web-based survey from the Brazilian IBD study group (GEDIIB)Roberta Krause Romero, Daniela Oliveira Magro, Natalia Sousa Freitas Queiroz, et al.Brazilian Journal of Anesthesiology (Elsevier)|April 6, 2025
Preoperative iron supplementation in non-anemic patients undergoing major surgery: a systematic review and meta-analysisFabio Vieira Toledo, Daniel De Carli, Jose Fernando Amaral Meletti, et al.Revista Da Associacao Medica Brasileira (1992)|May 9, 2019
Ulcerative colitis - treatment with biologicalsFabio Vieira Teixeira, Eduardo Garcia Vilela, Aderson Omar Mourão Cintra Damião, et al.Mutation Research. Genetic Toxicology and Environmental Mutagenesis|February 8, 2021
Metabolic activation enhances the cytotoxicity, genotoxicity and mutagenicity of two synthetic alkaloids with selective effects against human tumour cell linesJúlia Teixeira de Oliveira, Filipe Nogueira Franco, Kimberly Brito Tecchio, et al.Health Science Reports|April 11, 2025
Percutaneous Pulmonary Valve Implantation In Native Right Ventricular Outflow Tract Using Myval™ Without Pre-StentingJoão Luiz Langer Manica, Raul Ivo Rossi Filho, Carlos Augusto Cardoso Pedra, et al.Anti-Cancer Agents in Medicinal Chemistry|March 22, 2023
Genotoxicity and Anticancer Effects of the Aminothiophene Derivatives SB-44, SB- 83, and SB-200 in Cancer CellsEduardo Davi Lima da Silva, Flaviana Alves Dos Santos, Júlia Teixeira de Oliveira, et al.United European Gastroenterology Journal|April 15, 2017
Risk factors for complications after ileocolonic resection for Crohn's disease with a major focus on the impact of preoperative immunosuppressive and biologic therapy: A retrospective international multicentre studyTakayuki Yamamoto, Antonino Spinelli, Yasuo Suzuki, et al.Mutation Research. Genetic Toxicology and Environmental Mutagenesis|September 26, 2024
Evaluation of the in vivo acute toxicity and in vitro genotoxicity and mutagenicity of synthetic β-carboline alkaloids with selective cytotoxic activity against ovarian and breast cancer cell linesKimberly Brito Tecchio, Fernanda de Moura Alves, Janaina Domingas Alves, et al.Drug and Chemical Toxicology|July 1, 2024
In vitro evaluation of the selective cytotoxicity and genotoxicity of three synthetic ortho-nitrobenzyl derivatives in human cancer cell lines, with and without metabolic activationJúlia Teixeira De Oliveira, Kimberly Brito Tecchio, Marcela Silva Lopes, et al.Cytotechnology|March 22, 2017
Digoxin reduces the mutagenic effects of Mitomycin C in human and rodent cell linesJúlia Teixeira de Oliveira, Maria C da Silva Barbosa, Luiz F de Camargos, et al.Pageof 4